Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Alignment Healthcare (ALHC) EBIAT (2020 - 2025)

Alignment Healthcare's EBIAT history spans 6 years, with the latest figure at -$11.3 million for Q4 2025.

  • For Q4 2025, EBIAT rose 63.75% year-over-year to -$11.3 million; the TTM value through Dec 2025 reached -$1.2 million, up 99.04%, while the annual FY2025 figure was -$978000.0, 99.24% up from the prior year.
  • EBIAT reached -$11.3 million in Q4 2025 per ALHC's latest filing, down from $3.7 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $15.7 million in Q2 2025 to a low of -$57.0 million in Q4 2022.
  • Average EBIAT over 5 years is -$31.1 million, with a median of -$36.2 million recorded in 2023.
  • Peak YoY movement for EBIAT: tumbled 635.11% in 2021, then skyrocketed 165.21% in 2025.
  • A 5-year view of EBIAT shows it stood at -$47.8 million in 2021, then dropped by 19.15% to -$57.0 million in 2022, then rose by 17.13% to -$47.2 million in 2023, then surged by 34.23% to -$31.1 million in 2024, then skyrocketed by 63.75% to -$11.3 million in 2025.
  • Per Business Quant, the three most recent readings for ALHC's EBIAT are -$11.3 million (Q4 2025), $3.7 million (Q3 2025), and $15.7 million (Q2 2025).